Delta Becoming Globally Dominant: WHO
Geneva: The Delta variant, first identified in India, is becoming the globally dominant variant of the disease, the WHO’s chief scientist Soumya Swaminathan said on Friday. According to the Covid-19 Weekly Epidemiological Update issued by…
Zydus Cadila likely to seek emergency use authorisation for its Covid vaccine next week
Indian pharmaceutical major Zydus Cadila is likely to apply to the central drugs regulator seeking emergency use authorisation for its COVID-19 vaccine ZyCoV-D next week, official sources said on Friday. If approved, it will…
Single-Dose Cocktail Helping Patients Recover Faster: Docs
PUNE : Six mild to moderately ill Covid patients with multiple comorbid conditions showed faster recovery after taking the newest Covid medicine – a single-dose cocktail of monoclonal antibodies at…
Govt Job for Research Associate at AIIMS
All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the objects to develop patterns of teaching in Undergraduate and…
Novavax’s Covid-19 vaccine ‘Covavax’ to launch in India by September: Sources
The Serum Institute of India (SII) hopes to introduce US firm Novavax‘s Indian version of the Covid-19 vaccine – ‘Covavax‘ by September this year and start trials on children from July, sources said on Thursday.…
US Govt To Invest $3.2bn To Develop Pills To Treat Covid
Washington : The US is taking another medical moonshot to beat the pandemic, plowing in $3.2 billion to develop antiviral pills to treat Covid-19 infections. If all goes well, some…
DoP Invites Applications To Manufacture CDA And Artesunate Under PLI Scheme
Mumbai : The Department of Pharmaceuticals (DoP) has invited applications from eligible applicants to manufacture chemical synthesis based KSMs/drug intermediates (DIs) like cyclohexane diacetic acid (CDA) and other chemical synthesis…
Govt Job for the post of Chief Pharmacist at AIIMS
AIIMS Bhopal is a premier Institute of National Importance (INI) established by the Ministry of Health and Family Welfare, Government of India under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) with…
Why the interval between first and second Covishield doses must now be shortened
How did the dosing interval get longer? Two studies were cited mainly for increasing the interval. In a Lancet study published earlier this year, efficacy result in phase-3 clinical trial of two…
No newborn calf serum used in Covaxin, say Centre & BB
Hyderabad: Bharat Biotech on Wednesday said that though newborn calf serum is used in manufacturing of viral vaccines, it is not used in the final formulation of Covaxin. The statement came after an RTI query…
